News

RenoVō® Case Study: Inner Ear Squamous Cell Carcinoma
Written by : Renovo Equine

Case presentation: On November 3, 2022,

a 13 year-old Gelding Grade Horse presented to Topgun Veterinarian Service, Rock Hill, SC, with a mass in the right inner ear. The attending veterinarian, Dr. Audrey Turbeville, performed an excisional biopsy for pathology and debulked the mass. The pathology report interpretation was squamous cell carcinoma extending to the margins with no observed vascular invasion.

 

On November 3, 2022,

after the mass was debulked, a 1.5 cc RenoVo® allograft was implanted subcutaneously around the lesion at the discretion of the veterinarian.

 

On December 14, 2022,

just over one month following the RenoVo® implantation, the lesions had improved significantly with no evidence of the mass returning.

 

On February 7, 2023,

three months following the RenoVo® implantation, the right inner ear looked healthy and normal at examination with no sign of squamous cell carcinoma present.

Other Clinical Studies

What’s the Difference Between RenoVō® and PRGF?

What’s the Difference Between RenoVō® and PRGF?

Equine regenerative medicine is evolving quickly, and with that comes more choices. Two options you may be using or evaluating are PRGF (Plasma Rich in Growth Factors) and RenoVō®, an acellular equine amniotic tissue allograft. While both are used to support tissue,...

See all Clinical Studies